Molecular Reagent Starter Pack Xpert® MRSA NxG (Methicillin-Resistant Staphylococcus Aureus)

START PAK, XPERT MRSA N/S LF D/S

Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients
Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs
Between 2 and 53 million people are estimated to carry MRSA worldwide
More …

McKesson Item #1056403

Molecular Reagent Starter Pack Xpert® MRSA NxG (Methicillin-Resistant Staphylococcus Aureus)

Email To You may enter multiple email addresses separated by semicolons.

Email From

Message

Characters Left: 255

Send

View Alternatives

McKesson #

1056403

Manufacturer #

GXMRSA-NXG-SPAK

Brand

Xpert®

Manufacturer

Cepheid

Country of Origin

Unknown

Application

Molecular Reagent Starter Pack

Buy American Act (BAA) Compliant

Specialty

Molecular

Test Category

Other Infectious Disease

Test Format

Cartridge

Test Name

MRSA NxG (Methicillin-Resistant Staphylococcus Aureus)

Test Type

Molecular Diagnostic

Trade Agreement Act (TAA) Compliant

UNSPSC Code

41116011

Control of MRSA in healthcare settings requires rapid and accurate tests to detect colonized patients
Approximately 171,200 healthcare-associated MRSA infections are acquired annually in the European Union (EU), resulting in 5,400 attributable deaths, more than 1 million excess days of hospitalization and € 380 million in excess in-hospital costs
Between 2 and 53 million people are estimated to carry MRSA worldwide
The average length of stay (LOS) for all MRSA patients in the EU is 11.5 days with an average attributable cost of € 7,478 per patient